Evidence for the Existence of a Multidrug Efflux Transporter Distinct from NorA in <i>Staphylococcus aureus</i>

Glenn W. Kaatz, Susan M. Seo, Louise O’Brien, Mohammad Wahiduzzaman, Timothy J. Foster

Antimicrobial Agents and Chemotherapy · 2000 · 135 citations · 18 references

DOIFull text

Open access

Concepts

Abstract

A Staphylococcus aureus norA disruption mutant was created by allelic replacement. Exposure of this mutant to norfloxacin produced SA K1748, a derivative with raised fluoroquinolone MICs, found to be the result of a grlA mutation, and raised organic cation MICs. Ethidium and enoxacin uptake was identical in SA K1748 and its parent, but pre-exposure of SA K1748 to organic cations caused a reduction in ethidium uptake as a result of increased efflux. Altered ethidium uptake and efflux, as well as increased MICs of other organic cations, suggest that SA K1748 possesses a non-NorA multidrug efflux transporter that is inducible by its substrates.

References

18